X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA ALEMBIC LTD NATCO PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 32.4 75.2 43.0% View Chart
P/BV x 16.5 2.8 589.9% View Chart
Dividend Yield % 0.7 0.4 172.9%  

Financials

 NATCO PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
ALEMBIC LTD
Mar-16
NATCO PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs87753 1,661.0%   
Low Rs42429 1,445.4%   
Sales per share (Unadj.) Rs223.44.7 4,734.0%  
Earnings per share (Unadj.) Rs31.18.8 354.1%  
Cash flow per share (Unadj.) Rs40.39.0 447.3%  
Dividends per share (Unadj.) Rs5.000.15 3,333.3%  
Dividend yield (eoy) %0.80.4 210.4%  
Book value per share (Unadj.) Rs219.527.7 791.6%  
Shares outstanding (eoy) m33.07267.03 12.4%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.98.7 33.5%   
Avg P/E ratio x20.94.7 447.3%  
P/CF ratio (eoy) x16.14.6 354.1%  
Price / Book Value ratio x3.01.5 200.1%  
Dividend payout %16.11.7 941.3%   
Avg Mkt Cap Rs m21,50410,962 196.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1,128238 473.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m7,3891,260 586.3%  
Other income Rs m167264 63.3%   
Total revenues Rs m7,5561,524 495.8%   
Gross profit Rs m1,79383 2,165.8%  
Depreciation Rs m30461 495.8%   
Interest Rs m3660 122,066.7%   
Profit before tax Rs m1,290285 452.7%   
Minority Interest Rs m460-   
Prior Period Items Rs m02,096 0.0%   
Extraordinary Inc (Exp) Rs m0-32 0.0%   
Tax Rs m3096 5,060.7%   
Profit after tax Rs m1,0272,343 43.9%  
Gross profit margin %24.36.6 369.4%  
Effective tax rate %23.92.1 1,117.8%   
Net profit margin %13.9185.9 7.5%  
BALANCE SHEET DATA
Current assets Rs m3,6811,689 218.0%   
Current liabilities Rs m3,123486 642.3%   
Net working cap to sales %7.695.4 7.9%  
Current ratio x1.23.5 33.9%  
Inventory Days Days89217 41.2%  
Debtors Days Days5981 72.4%  
Net fixed assets Rs m7,6851,624 473.2%   
Share capital Rs m331534 61.9%   
"Free" reserves Rs m6,6705,960 111.9%   
Net worth Rs m7,2597,404 98.0%   
Long term debt Rs m955104 915.5%   
Total assets Rs m11,9578,010 149.3%  
Interest coverage x4.5950.7 0.5%   
Debt to equity ratio x0.10 933.8%  
Sales to assets ratio x0.60.2 392.8%   
Return on assets %11.729.3 39.8%  
Return on equity %14.231.6 44.7%  
Return on capital %20.731.3 66.2%  
Exports to sales %39.42.9 1,336.9%   
Imports to sales %5.728.9 19.8%   
Exports (fob) Rs m2,90837 7,837.7%   
Imports (cif) Rs m421364 115.8%   
Fx inflow Rs m3,44537 9,286.8%   
Fx outflow Rs m703365 192.6%   
Net fx Rs m2,743-328 -836.6%   
CASH FLOW
From Operations Rs m1,440346 416.8%  
From Investments Rs m-1,089-48 2,288.2%  
From Financial Activity Rs m-353-301 117.2%  
Net Cashflow Rs m-1-3 49.7%  

Share Holding

Indian Promoters % 52.0 64.0 81.3%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 0.2 3,920.0%  
FIIs % 16.6 9.7 171.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 26.1 99.6%  
Shareholders   25,395 54,701 46.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   FULFORD INDIA  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT LTD.  SUN PHARMA  

Compare NATCO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - DR. REDDYS LAB COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS